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Dengue represents a major public health problem in Thailand, with all four viral serotypes co-circulating. Dengue virus serotype 4
(DENV-4) is the least frequently sampled serotype, although one that is often associated with hemorrhagic fever during secondary infection.
To determine the evolutionary forces shaping the genetic diversity of DENV-4, and particularly whether its changing prevalence could be
attributed to instances of adaptive evolution in the viral genome, we undertook a large-scale molecular epidemiological analysis of DENV-4
in Bangkok, Thailand, using both E gene and complete coding region sequences. This analysis revealed extensive genetic diversity within a
single locality at a single time, including the discovery of a new and divergent genotype of DENV-4, as well as a pattern of continual lineage
turnover. We also recorded the highest average rate of evolutionary change for this serotype, at 1.072  103 nucleotide substitutions per site,
per year. However, despite this abundant genetic variation, there was no evidence for adaptive evolution in any gene, codon, or lineage of
DENV-4, with the highest rate of nonsynonymous substitution observed in NS2A. Consequently, the rapid turnover of DENV-4 lineages
through time is most likely the consequence of a high rate of deleterious mutation in the viral genome coupled to seasonal fluctuations in the
size of the vector population.
D 2004 Elsevier Inc. All rights reserved.
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Dengue is the most prevalent vector-borne viral infection
of humans; each year, an estimated 100 million people
suffer an acute febrile illness designated dengue fever (DF),
while at least 250000 experience the far more serious
condition of dengue hemorrhagic fever (DHF), which is0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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1 These authors have contributed equally to this study.associated with case fatality rates of up to 15% depending
on the availability of appropriate clinical management
(Gubler, 2002). As well as its public health burden,
dengue-associated illness is responsible for considerable
monetary losses from lost work hours and tourism, and the
virus may be expected to grow in prevalence due to such
factors as human population size growth, international
transportation systems, and global warming. As dengue
vaccine development is actively underway, an understand-
ing of the evolutionary factors that determine viral genetic
diversity is of utmost importance.
Dengue viruses are single-stranded positive-sense RNA
viruses (genus Flavivirus) that are assigned to four antigeni-
cally distinct serotypes—denoted DENV-1 to DENV-4.
These viruses now co-circulate in many parts of the tropical
and subtropical world following the geographical distribu-04) 168–179
C. Klungthong et al. / Virology 329 (2004) 168–179 169tion of Aedes sp. mosquitoes. The viral genome, which is
translated as a single polyprotein, encodes three structural
proteins (C, M, and E) and seven nonstructural proteins
(NS1, NS2a, NS2b, NS3, NS4a, NS4b, and NS5).
In recent years, considerable attention has been directed
toward characterizing the extent of genetic diversity in each
of the four serotypes of dengue virus, particularly through
the sequencing and phylogenetic analyses of complete
envelope (E) gene sequences from strains sampled globally
(reviewed in Holmes and Twiddy, 2003). In general, these
studies reveal that strains of dengue virus from individual
serotypes often fall into well-defined phylogenetic groups
supported by high bootstrap values, which may be called
bgenotypesQ or bsubtypesQ (although such definitions are
likely to change with increased sampling). A more revealing
pattern is that viral genotypes often have differing patterns
of geographic distribution, with some restricted to particular
geographic regions (notably Southeast Asia), while others
are found in more diverse geographical localities, reflecting
the extensive migration of both infected hosts and vectors.
For example, in DENV-2, where E gene sequence data is
particularly abundant, some genotypes have distributions
that cover much of the land mass within the tropics of
Cancer and Capricorn, so that they can be thought of as
having a bcosmopolitanQ geographic structure (Twiddy et al.,
2002a). In sum, the current genetic structure of dengue virus
populations appears to reflect an intricate pattern of gene
flow, most likely caused by the movement of infected
humans, and population subdivision, as the virus spreads
within local communities, highlighting the complex epide-
miological history of these viruses in the 20th century
(Holmes and Twiddy, 2003). Finally, in the case of DENV-2
and DENV-4, genotypes confined to a sylvatic (or bjungleQ)
cycle have also been described (Wang et al., 2000). Here,
dengue viruses circulate exclusively in nonhuman primates
and are transmitted by a variety of rural Aedes species. It is
likely that phylogenetically distinct sylvatic genotypes also
occur in DENV-1 and DENV-3.
Thailand is representative of countries that experience
annual dengue virus transmission with the co-circulation of
all four virus serotypes. Since its first appearance in the late
1950s, DHF case numbers have increased, albeit with
changing frequencies of isolation of each serotype and an
oscillation between relatively low and high dengue case
years (Nisalak et al., 2003), most likely reflecting complex
immunodynamics. Although DENV-4 is the least frequently
isolated serotype, has not been associated with severe
dengue outbreaks, and is responsible for only 2% of dengue
cases observed at the Queen Sirikit National Institute of
Child Health (QSNICH) in Bangkok (formerly known as
Bangkok Children’s Hospital) between 1973 and 1999, it
was the predominant serotype during 1993 and 1994
(Nisalak et al., 2003). More strikingly, despite the low
prevalence of DENV-4, it was responsible for 10% of DHF
cases in children; the vast majority of DENV-4 DHF cases
(359 of 368) being associated with secondary dengue virusinfection (Nisalak et al., 2003). This implies that DENV-4
requires the action of heterologous immune factors (e.g.,
antibodies vis-a-vis antibody-dependent enhancement) to
cause severe manifestations of disease. Thailand also
represents an ideal locality to document the molecular
epidemiology of dengue virus. Not only is dengue a major
public health problem in this country, but associated
epidemiological data is available, so that the dynamics of
this virus infection can be investigated with relative
precision. Such a study recently revealed that DHF
epidemics in Thailand occur on a 3-year cycle, spreading
in waves from an origin in Bangkok (Cummings et al.,
2004).
Although dengue virus is comprised of four distinct
serotypes, relatively few comprehensive studies of DENV-4
genetic diversity have been undertaken, particularly in
Southeast Asia. DENV-4 is of particular interest in that it
is the first dengue serotype to diverge in phylogenetic
analyses of the genus Flavivirus (Gaunt et al., 2001; Kuno
et al., 1998; Jenkins et al., 2001), so that it may have
developed unique phenotypic features, and is generally
found at low frequency in Southeast Asia. Early molecular
epidemiological studies confirmed that DENV-4 could be
divided into a series of discrete genotypes (Chungue et al.,
1995; Lanciotti et al., 1997), although some intragenotype
recombination has also been observed (AbuBakar et al.,
2002; Worobey et al., 1999). To date, three major genotypes
of DENV-4 virus have been described (Lanciotti et al.,
1997); one found in Southeast Asia (genotype I), a second
described in Southeast Asia and the Americas (genotype II),
and a third found exclusively as sylvatic strains in Malaysia.
More recently, extensive molecular epidemiological studies
have documented the spread of DENV-4 in the Caribbean,
most notably Puerto Rico, where genotype II seems to have
become established since the early 1980s after having been
imported from Southeast Asia (Bennett et al., 2003; Foster
et al., 2003). In particular, a large-scale analysis of DENV-4
genetic diversity in Puerto Rico produced phylogenetic trees
with a strong temporal structure, such that the position of
lineages generally corresponded to their time of sampling;
for example, the oldest viral strains, sampled in 1981–1982,
fell nearest the root of the tree, while the most recently
sampled strains fell furthest from the root (Bennett et al.,
2003). Moreover, the major epidemic of DF associated with
DENV-4 that affected Puerto Rico in 1998 was linked to a
high ratio of nonsynonymous (dN) to synonymous (dS)
substitutions per site in the NS2A protein, corresponding to
three amino acid changes (at residues 14, 54, and 101). In
contrast, the strongly antigenic E protein remained highly
conserved in sequence over the 17-year sampling period.
This was interpreted to mean that a selectively favored strain
of DENV-4 was responsible for the surge of dengue in 1998,
and the overall temporal structure of the tree, but that this
selection pressure did not involve mechanisms to escape
from neutralizing antibodies. Although the selection pres-
sures acting on NS2A remain unclear, it is noteworthy that
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opes in the nonstructural genes has been documented, and
may play a key role in dengue pathogenesis (Mongkolsa-
paya et al., 2003).
In this paper, we present the results of an extensive
molecular epidemiological analysis of DENV-4 in Bangkok,
Thailand, to determine the structure of viral genetic diversity
in this locality and the evolutionary processes responsible
for this structure. In particular, we wished to determine
whether the change in DENV-4 prevalence through time
could be associated with specific genetic changes in the
viral genome; that is, to what extent does adaptive evolution
in the viral genome influence long-term epidemiological
patterns? To this end, we have sequenced the E gene
sequences from 53 dengue viral isolates recovered during a
27-year period in Thailand and further determined the
complete coding region of the viral genome from six of
these strains.Results
Prevalence of DENV-4
The changing prevalence of DENV-4 in Thailand is
shown in Fig. 1. This is characterized by distinct outbreaks
of 3–5-year duration interspersed between periods of
relatively little disease/virus isolation. As has been observed
in other studies of viral genetic diversity (Shurtleff et al.,
2001; Uzcategui et al., 2003), there was no obvious
association between disease status and the phylogenetic
position of their associated DENV-4 strains; strains asso-
ciated with DHF fell indiscriminately on the phylogenetic
tree and did not tend to group together. Hence, DHF is notFig. 1. The total cases of DENV-4 recorded in children at the QSassociated with a specific DENV-4 E gene sequence. As
described below, the most important factor shaping the
DENV-4 tree was the time of sampling.
Molecular epidemiology of DENV-4 viruses
Our phylogenetic analysis of 109 E gene sequences
shows that DENV-4 viruses sampled globally can be placed
into four distinct and well-supported groups, which can be
thought of as genotypes, one of which is only found in
nonhuman primates in Malaysia (Fig. 2). The majority of
the Thai DENV-4 strains sampled here fell into the
previously described genotypes I and II; 47 fell into
genotype I that has been widely reported in Asiatic regions,
including Thailand, while a single strain (ThD4-0734/00)
fell into a subclade of genotype II. The latter appears to have
an Asian origin and was then exported to Latin America,
The Caribbean (and also the South Pacific), where it has
evolved in situ for almost 25 years.
The most striking observation, however, was that five of
the Thai viruses obtained here fell into a phylogenetic group
that has not been described previously, is distinct from the
other Thai viruses, and seemingly the first human lineage of
DENV-4 virus to diverge. This is denoted bgenotype IIIQ in
Fig. 2. Not only is this new genotype phylogenetically
distinct (although its position relative to the other two
human genotypes in the E gene could not be assigned with
certainty in the bootstrap analysis), but it is comprised of
Thai DENV-4 strains sampled relatively recently, from 1997
to 2001. This suggests two possibilities: strains of this new
and divergent DENV-4 genotype existed before 1997 but
had not been sampled previously, or the genotype came into
existence recently following a recombination event between
diverse DENV-4 viruses.NICH, Bangkok, Thailand during the period 1973 to 2002.
Fig. 2. Maximum likelihood (ML) phylogenetic tree of 109 E sequences of DENV-4 sampled on a global basis. The four viral genotypes, including that newly
described here (III), are indicated. Bootstrap support values (where N90%) are shown for a number of key nodes on the tree. The tree is rooted by the two
sylvatic (nonhuman primate) strains and all horizontal branch lengths are drawn to scale.
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4 is a product of divergent evolution or recombination, we
compared complete coding regions from six Thai strains
representing the full phylogenetic diversity of DENV-4 in
this country, including two from the new genotype III
(strains ThD4-0017/97 and ThD4-0476/97), as well as twocomplete DENV-4 genomes available on GenBank (Domi-
nica/81 and China.Guangzhou.B5). These eight strains
cover the full phylogenetic diversity of human DENV-4.
Phylogenetic trees were estimated for all 10 genes from
these 8 viral strains. In every case, strains ThD4-0017-97
and ThD4-0476/97 fell into a separate and divergent clade,
C. Klungthong et al. / Virology 329 (2004) 168–179172confirming that they constitute an entirely new genotype of
DENV-4 and are not the product of recombination (trees
not shown; available upon request). As expected, the
divergent phylogenetic position of genotype III was also
observed on a phylogenetic tree of the complete coding
region from 58 viral isolates (Fig. 3). In this case, the early
division of genotype III was also supported by a high
number of bootstrap replications, indicating that this
genotype indeed has a long independent evolutionary
history.
The phylogenetic tree of the DENV-4 E gene produced
here is also notable for its strong temporal structure,
particularly in the Thai DENV-4 strains assigned to
genotype I; viral strains isolated at the earliest time pointsFig. 3. ML phylogenetic tree of 58 complete coding regions (10185 bp) from d
DENV-4 are indicated. Bootstrap support values (where N90%) are shown for node
DENV-4. The tree is mid-point rooted for purposes of clarity only and all horizo(such as ThD4-0087/77 sampled in 1977) tended to fall near
the root on the phylogenetic tree, while those sampled more
recently (such as ThD4-0352/02 from 2002) were located at
the most distal tips. This temporal ordering is caused by the
continual emergence and extinction of viral lineages; new
lineages are regularly produced by mutation, but most go
extinct relatively rapidly and few progress to subsequent
sampling times. A particularly clear example of this process
of strain turnover seems to have taken place during 1998–
1999; all Thai strains sampled from genotype I from 2000 to
2002, as well as one strain from 1998 and two from 1999,
fell into a distinct and well-supported clade on the
phylogenetic tree that is separate from those sampled in
earlier years (highlighted in Fig. 2). This suggests that anengue viruses, including 8 from DENV-4. The three human genotypes of
s depicting the relationships of the four viral serotypes and new genotype of
ntal branch lengths are drawn to scale.
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in 1999.
Selection pressures in DENV-4
To determine the nature of the selection pressures acting
on DENV-4, we undertook an extensive analysis of the
numbers of synonymous (dS) and nonsynonymous (dN)
changes per site, at the gene, codon, and lineage levels. This
analysis confirmed recent reports that the predominant
evolutionary force acting on this virus is relatively strong
purifying selection (Twiddy et al., 2002b; Woelk and
Holmes, 2002). In all viral genes analyzed, dS greatly
exceeded dN, indicating that purifying selection is strong
(Table 1). In terms of increasing selective constraint
(decreasing dN/dS), the order of genes was as follows:
NS2A, C, NS1, NS2B, E, NS4A, NS5, M, NS3, NS4B, with
a 6.8-fold variation in dN/dS across genes (ranging from
0.013 to 0.088).
A similar picture of strong purifying selection was
observed in the codon and lineage-specific analysis of dN/
dS. At the codon level, there was no evidence for positive
selection at any individual codon in the sequence align-
ment (the neutral M7 model could not be rejected by the
selection M8 model, P = 0.225), and although there was
evidence for lineage-specific variation in dN/dS (M0 was
significantly rejected by FR, P = 0.012), no individual
lineage was distinguished by an unusually high dN/dS, as
expected if positive selection had been in operation.
Indeed, under M0, the mean dN/dS across the tree was
0.055, again indicating that purifying selection dominates
DENV-4 evolution.
Rates of evolution in DENV-4
The strong temporal structure of DENV-4 in Thailand
also allowed us to estimate the rates of molecular evolution
(nucleotide substitution) of this virus. Using a Bayesian
MCMC method, we estimated that the overall substitution
rate of DENV-4 in 47 Thai (Bangkok) isolates spanning the
years 1976 to 2002 and assigned to genotype I was on
average 1.072  103 substitutions/site/year (highestTable 1
Selection pressures in DENV-4 on a gene-by-gene basis
Protein Length
(amino acids)
dN dS dN/dS
Capsid 113 0.013 0.229 0.057
Membrane 166 0.008 0.400 0.020
Envelope 495 0.011 0.335 0.033
NS1 352 0.015 0.335 0.045
NS2A 218 0.031 0.354 0.088
NS2B 130 0.009 0.245 0.037
NS3 618 0.005 0.342 0.015
NS4A 150 0.013 0.436 0.030
NS4B 245 0.005 0.372 0.013
NS5 900 0.008 0.337 0.024posterior density [HPD] of 0.841  103–1.311  103).
This falls within the range seen in other RNA viruses
(Jenkins et al., 2002).Discussion
The molecular epidemiology of DENV-4
We have performed the most extensive molecular
epidemiological study of DENV-4 to date. Strikingly, three
different viral genotypes were found in a single location—
Bangkok, Thailand—at equivalent sampling times.
Although viruses assigned to genotype I were the most
common form isolated, it is clear that Bangkok acts as a
major reservoir for dengue virus diversity. This may also
explain why Bangkok has been identified as the epicenter
for DHF in Thailand (Cummings et al., 2004). Of the three
genotypes present in Bangkok, one (genotype III) is newly
identified, and is also the most divergent human strain of
DENV-4 identified to date. It is likely that a more extensive
sampling procedure would reveal more genetic diversity
within DENV-4, including other members of genotype III
and perhaps novel genotypes.
Although the geographic range of current DENV-4
sampling is limited, it is notable that all the human
genotypes of DENV-4 were present in Southeast Asia,
particularly Thailand, and that the sylvatic genotype has
been found in monkeys in Malaysia. At face value, this
suggests that the ultimate origin of DENV-4 might lie in
Southeast Asia. Such an interpretation is supported by the
observation that even in the cosmopolitan genotype II,
which contains isolates from a wide range of geographical
locations, those from Asia (including ThD4-0734/00) fall at
the deepest locations on the molecular tree. Hence, it
appears that Southeast Asia serves as the source population
for dengue virus strains that have subsequently spread
throughout the tropical world since World War II. Con-
firmation of this hypothesis will require analysis of a
broader geographical sampling of DENV-4 strains, particu-
larly from Africa where sampling has traditionally been
sparse.
A greater challenge is to explain the strong temporal
structure of the DENV-4 E gene phylogenies, particularly
over an approximately 30-year sampling period in Thailand.
At one level, the high rate of lineage extinction observed,
producing the distinctive ladder-like phylogeny, could be
taken as evidence for continual immune-driven positive
selection as similarly shaped phylogenies have been
observed for the hemagluttinin (HA) gene of human
influenza A virus sampled at the interhost level, and the
envelope gene of HIV-1 serially sampled within individual
hosts (reviewed in Grenfell et al., 2004). In these cases, the
short side branches represent lineages that are eventually
removed from the population by cross-protective immune
responses, while the main trunk of the tree (i.e., that
C. Klungthong et al. / Virology 329 (2004) 168–179174connects viruses from different sampling times) traces the
antigentically favored strains through time. However, we
found no evidence for positive selection on any branch or
codon in the E gene, in contrast to the powerful selection
observed in both interhost influenza A (Bush et al., 1999)
and intrahost HIV (Williamson, 2003). Indeed, the very low
dN/dS values observed in DENV-4 reveal a strong force of
purifying selection. Such powerful purifying selection has
also been noted by the dramatic reduction in dN/dS within
infected populations compared to that observed within
infected individuals; this strongly suggests that the vast
majority of amino acid changes that arise within infected
hosts are deleterious in the long term and eventually are
removed from the population by purifying selection
(Holmes, 2003; Wittke et al., 2002). A more likely
explanation for the ladder-like DENV-4 phylogeny and the
high rate of lineage extinction is therefore a regular series of
population bottlenecks, probably caused by seasonal fluc-
tuations in the size of the mosquito population, coupled with
a high rate of deleterious mutation. Similar instances of
lineage replacement, thought to be the outcome of popu-
lation bottlenecks, have previously been observed in both
DENV-2 and DENV-3 in Thailand (Sittisombut et al., 1997;
Wittke et al., 2002). In sum, we suggest that the dynamics of
mosquito transmission may mean that population bottle-
necks and rapid lineage turnover are a common observation
in dengue virus evolution. As such, the pattern of viral
evolution observed is more likely to be a consequence of
large-scale epidemiological factors than the cause of
changing patterns of prevalence.
The molecular evolution of DENV-4
Our relatively large DENV-4 data set enabled us to
undertake an extensive study of the molecular evolution of
this virus. First, by using the detailed temporal sampling of
DENV-4 strains, we were able to obtain a precise estimate of
the rate of molecular evolution (nucleotide substitution) in
this virus. The mean rate estimated—1.072  103
substitutions/site/year—is noteworthy in that it is one of
the highest rates estimated for dengue virus to date,
particularly for DENV-4 (Twiddy et al., 2003). More
specifically, the rate is approximately twice that (0.542 
103 substitutions/site/year) estimated by Twiddy et al.
(2003) on the same genotype using similar methods
although with a much smaller data set, over 35% greater
than DENV-4 rate (0.77  103 substitutions/site/year)
obtained in the large comparative study of Jenkins et al.
(2002), and more than 20% higher than the overall DENV-4
rate (0.83  103 subs/site/year) estimated by Lanciotti et
al. (1997) using a simpler linear regression method.
Whether the relatively high substitution rate estimated here
reflects the high turnover of DENV-4 in Thailand, or is
simply a reflection of more extensive sampling, is unclear.
However, because we have identified a signal of strong
purifying selection in DENV-4 coupled with a process oflineage extinction, all the substitution rates estimated for
dengue virus to date are possibly slight overestimates
because deleterious mutations that have yet to be selectively
purged from the population are still included in the sample.
A second important insight into the molecular evolution
of DENV-4 comes from our gene-specific analysis of the
selection pressures acting on the complete coding region of
the virus genome. In particular, we found that some of the
nonstructural genes, most notably NS2A, exhibited higher
levels of nonsynonymous variation than the structural and
antigenic E gene, which is often thought to harbor the
greatest amount of genetic diversity because of antibody-
mediated selection. As noted above, the maximum like-
lihood analysis of selection pressures in the E gene also
revealed a process of strong purifying selection. The basis of
the (relatively) high level of genetic variation in NS2A is
unclear and requires further explanation. Although there
was insufficient data to undertake a codon-specific analysis
of selection pressures, nucleotide substitutions in this gene
were previously cited as the virological cause of a recent
epidemic of DENV-4 in Puerto Rico (Bennett et al., 2003)
and another nonstructural gene, NS3, has been found to
harbor T-cell epitopes (Mongkolsapaya et al., 2003). As
such, our results suggest that more attention be directed
toward the nonstructural genes as a source of adaptively
relevant genetic variation, particularly NS2A.Materials and methods
Specimen data
DENV-4 was isolated from 53 children (mean age = 8.7
years) hospitalized at QSNICH over a 27-year period
spanning 1976 to 2002 (Table 2). Of these, 21 were
associated with DF and 32 with DHF. Grading of these
diagnostic specimens was conducted by QSNICH physi-
cians using WHO classification guidelines. Further testing
at AFRIMS characterized the specimens according to their
dengue virus serotype and nature of the dengue virus
infection. Primary versus secondary DENV-4 infection was
determined solely by hemagglutination assay inhibition
(HAI) before 1990 and by MAC-ELISA supported by
HAI subsequently. Viral collections before 1980 had been
isolated after two to three serial passages in LLC-MK2 cells,
whereas subsequently they were isolated after amplification
in Toxorhynchites splendens mosquitoes followed by one to
three passages in C6/36 cells.
RNA extraction and reverse transcriptase-polymerase chain
reaction (RT-PCR) amplification
Virus RNA was extracted from cell culture supernatant
using Trizol (GIBCO BRL) reagent. One milliliter of Trizol
was mixed with 100 Al of each DENV-4 virus and 200 Al of
RNase-free chloroform (Sigma) was added to each sample
Table 2
Description of DENV-4 isolates sequenced in this study
a The middle numeral is the sample number while the last two numerals indicate the year of isolation. The highlighted (gray color) samples were those selected
for complete genome sequencing.
b F is female and M is male.
c Unclassified grade.
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centrifuged at 12000  g at 10 8C for 15 min, and
supernatant was taken to mix with 500 Al of isopropanol
and then kept at room temperature for 5 min before
centrifugation at 12000  g at 20 8C for 10 min. Each
pellet was washed with 1 ml of 75% ethanol and centrifuged
at 12000  g at 20 8C for 2 min. The RNA pellet was dried
at room temperature for 30 min, and then resuspended in 25
Al of RNase-free water (Sigma). The RNA solution was used
for RT-PCR. Oligonucleotide primers for RT-PCR amplifi-
cation and sequencing were designed by using Primer
Design program (http://www.hgmp.mrc.ac.uk/GenomeWeb/
nuc-primer.html). The sequences and positions of primers for
DENV-4 genome are shown in Table 3. All specimens used
for sequencing were pretested by using a Lanciotti RT-PCR
and nested PCR to confirm correct viruses for the DENV-4
serotype and to adjust virus concentration. The RT-PCR was
performed according to the protocol of Lanciotti et al.
(1992).
Sequencing and analysis
DENV-4 genomic RNAwas converted to cDNA by using
random hexamer oligonucleotides with SuperScript First-Strand Synthesis System (Invitrogen) according to the
manufacturer’s instructions. The DNA fragments of the E
gene for all 53 DENV-4 and eight overlapping DNA
fragments that covered the entire DENV-4 genome for each
of isolates ThD4-0087/77, ThD4-0348/91, ThD4-0017/97,
ThD4-0476/97, ThD4-0734/00, and ThD4-0485/01 (Fig. 4)
were amplified by PCR with Taq DNA polymerase and eight
pairs of primers described in Fig. 4 and Table 3. The PCR-
amplified DNA fragments were purified using Qiagen PCR
purification kits (Qiagen, Germany) according to the manu-
facturer’s instructions. Purified DNA fragments were used
for sequencing. For an unknown reason, only forward
direction sequencing was available for regions nt 9708–
9943 and nt 10178–10653 of sample ThD4–0476/97 and nt
9679–9943 and nt 10451–10649 of sample ThD4–0485/01.
However, in all cases, the chromatography peak for each base
was unambiguous.
Cycle sequencing reactions were performed using
DYEnamic ET Dye Terminator Sequencing Kit (Amersham
Pharmacia Biotech), according to the manufacturer’s
instructions, with sequencing primers described in Table 3.
The sequencing products were cleaned by standard precip-
itation before sequencing on a MegaBASE 500 automated
DNA sequencer (Amersham Pharmacia Biotech). Over-
Table 3
DENV-4 sequencing primers used in this study
Namea Sequence (5VY3V) Positionb Namea Sequence (5VY3V) Positionb
5VD4F1c AGTTGTTAGTCTGTGTGGACC 1–21 3VD4R235 ATCCGTAAGGGTCCTTTCC 217–235
5VD4F136 TCAATATGCTGAAACGCGCGAGAAACCG 136–163 3VD4R646 TTGCACCAACAGTCAATGTCTTCAGGTTC 618–646
5VD4F717c GTAGCTTTAACACCACATTC 717–736 3VD4R836c TCCTGGGTTTCTGAGTATCCA 816–836
5VD4F1162 CAACGCAAGGAGAGCCTTA 1162–1180 3VD4R1285 CATGTCACAACTCCTCCTT 1267–1285
5VD4F1631 GAATTACAAAGAGAGAATGGT 1631–1651 3VD4R1847 TGAACACATCGTGTATGAC 1829–1847
5VD4F2064 AGCTACATAGTGATAGGTGT 2064–2083 3VD4R2163 CACCTCTGTATGTGGACTC 2145–2163
5VD4F2373c TGCATAGCTGTTGGAGGAAT 2373–2392 3VD4R2519c GTACTGTTCTGTCCAAGTGT 2500–2519
5VD4F2824 TAATAGACGGACCAGACAC 2824–2842 3VD4R2772 TCTTCCATGAATATTTCAGA 2753–2772
5VD4F3244 AGATAGACTTTGGAGAATGC 3244–3263 3VD4R2773 GTCTTCCATGAATATTTCA 2755–2773
5VD4F3543c TGCTTGAGGAGAAGAGTCAC 3543–3562 3VD4R3191 GTAATTGTGCTGTGAAAAAG 3172–3191
5VD4F3564 AGGAAACACATGATATT 3564–3580 3VD4R3270 TTCCGGGGCATTCTCCAA 3253–3270
5VD4F3992 GTTTGTGGTCACACTCATT 3992–4010 3VD4R3642c GTAGTAAGTCCATCCATGTG 3623–3642
5VD4F4439 ACTGATAACAGTGTCAGGTC 4439–4458 3VD4R4111 AGAGTCATTAGGTACACTGG 4092–4111
5VD4F4883 TGGAGAAATTGGAGCAGTA 4883–4901 3VD4R4128 TTGAGGCTCCTTTCATGAG 4110–4128
5VD4F5298 CTCATGTGTCATGCAACCT 5298–5316 3VD4R4519 TGTGTT(T,C)TCACTTGCCA 4503–4519
5VD4F5313c ACCTTCACAACAAGACTTTT 5313–5332 3VD4R4528 CCTGATCTTTGTGTTTTCAC 4509–4528
5VD4F5788 TGATAGACC(C,T)CAGGAGATG 5788–5806 3VD4R4972 TAGAGTCCGATGACTTTTCC 4953–4972
5VD4F5862 ATTCCAGTGACTCCAGCA A 5862–5880 3VD4R5005 TAATCACCTGATTTGGT 4989–5005
5VD4F6343 TGAAGGATTTCAAGGAGT 6343–6360 3VD4R5383c TGTGCTTCATCCATCACTAT 5364–5383
5VD4F6441 AAGCT(C,A)GCCCTTGACAA 6441–6457 3VD4R5717 TTTCGTTTTTGGATACTCT 5699–5717
5VD4F6783 TACGTCATATTGACCATTCT 6783–6802 3VD4R5758 TCAGATATGTCTGT(G)GT 5742–5758
5VD4F6796 CCATTCTCAC(T,C)ATTATTG 6796–6813 3VD4R6160 AGCCACACCGGAAGGTCT 6143–6160
5VD4F6975c AGACACACCATAGAAAACAC 6975–6994 3VD4R6180 CAGAAGCTACCTTATAGCTC 6161–6180
5VD4F7401 ACTTTGGCCACAGGACCA 7401–7418 3VD4R6676 ATTTCTGC(C,T)ACCCAGAG 6660–6676
5VD4F7414 GACCAATCTTGACCTTGT 7414–7431 3VD4R7127c GTTCACTTGAGAATAGCATC 7108–7127
5VD4F7882 GTCCAGGACATGAAGAAC 7882–7899 3VD4R7470 CTATGGTCGTGTTCCAAA 7453–7470
5VD4F8350c GAAGTGTCTCCACTGAAAC 8350–8368 3VD4R7905 GAATCGGTTCTTCATGTC 7888–7905
5VD4F8645 CAGAACACCACAACCAAA 8645–8662 3VD4R8326 TCCTTCTCATA(A,G)GTGGG 8310–8326
5VD4F8682 ATGACCAC(G,A)ACAGCCAA 8682–8698 3VD4R8331 CTACGTCCTTCTCATAAGTG 8312–8331
5VD4F9069 TCATGGAGTGGA(G,C)TGGAA 9069–9086 3VD4R8768c TTTTGAGATGAACTCTTCC 8750–8768
5VD4F9070 CATGGAGTGGAGTGGAAG 9070–9087 3VD4R9302 GACTTTCACCACTTTGTTT 9284–9302
5VD4F9481 TGAAAGAAAGAGT(T,C)GAGA 9481–9498 3VD4R9375 CAAC(C,T)TGTCCACTACCT 9359–9375
5VD4F9485c AGAAAGAGTTGAGAAATGG 9485–9503 3VD4R9750 TACA(T,C)GGAACAACCAGTGA 9732–9750
5VD4F9944 AACATGGTCAATCCACGC 9944–9961 3VD4R9764c TTCATCCTGGTTTCTACAT 9746–9764
5VD4F9984 GAAGA(T,C)ATGCTCAAAGTG 9984–10001 3VD4R10180 TTCCTGAC(C,T)TGGGTTATG 10163–10180
5VD4F10411 ATATTGGACTAGCGGTTAGA 10411–10430 3VD4R10228 CTT(C,T)TCATGACTGGCATGT 10210–10228
3VD4R10649c AGAACCTGTTGGATCAAC 10632–10649
a Primer names with F indicate forward direction and R indicate reverse direction.
b Based on the nucleotide numbering of DENV-4 strain 814669 (GenBank Accession No. AF326573).
c These primers were used for both amplification and sequencing.
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Fig. 4. Schematic diagram of the DENV-4 genome comprising eight overlapping DNA fragments. The relative positions of primers used in PCR to generate
these DNA fragments are shown.
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and edited with the aid of the Sequencher software (Gene
Code Corp., USA). All sequences produced here have been
submitted to GenBank (accession numbers AY618935–
AY618993). The other dengue virus isolates used in this
analysis are listed in Table 4.Table 4
Sequences from other dengue virus isolates used in this analysis
Country of origin Yeara Accession Country of origin Y
Bahamas.A/98b 1998 AY152364 Puerto Rico.96/90b 1
Bahamas.C/98b 1998 AY152366 Puerto Rico.84/94b 1
Barbados.A/93b 1993 AY152375 Puerto Rico.17/98b 1
Barbados.B/93b 1993 AY152376 Sri Lanka.S-44750/78b 1
Barbados/99b 1999 AY152368 Surinam.B/82b 1
Brazil.1385/82b 1982 U18425 Surinam.A/94b 1
Cambodia.NIID/02b 2002 AB111089 Surinam.B/94b 1
China.Guangzhou.B5b NAd AF289029 Surinam.C/94b 1
Dominica.M44/81b 1981 AY152360 Tahiti.S-44754/79b 1
El Salvador.1411/83b 1983 U18426 Tahiti.114-094-85/85b 1
ElSalvador.BC6494/94b 1994 U18427 Thailand.TC2443/63b 1
Honduras/91b 1991 AY152379 Thailand/78b 1
India.NIID/96b 1996 AB111086 Thailand/84b 1
Indonesia.30153/73b 1973 U18428 Thailand.703-4/94b 1
Indonesia.1036/76b 1976 U18429 Thailand.NIID/99b 1
Indonesia.1132/77b 1977 U18430 Trinidad.A/82b 1
Indonesia.NIID/02b 2002 AB111088 Trinidad.B/82b 1
Jamaica/81b 1981 AY152389 Trinidad.A/84b 1
Jamaica/83b 1983 AY152384 Trinidad.B/84b 1
Malaysia.P7-1006/73b 1973 AF231722 Trinidad/94b 1
Malaysia.1120/73b 1973 AF231724 16607c N
Malaysia.514/75b 1975 AF231723 Indonesia.A88/88c 1
Mexico/91b 1991 AY152378 Argentina.293/00c 2
Mexico.1492/84b 1984 U18431 Argentina.295/00c 2
Montserrat.A/94b 1994 AY152369 Argentina.297/00c 2
NewCaledonia.5489/84b 1984 U18432 Argentina.301/00c 2
NIID/61b,e 1961 AB111090 Australia.TSV01/93c 1
Philippines.H-241/56b 1956 U18433 Brazil/90c 1
Philippines.16589/64b 1964 U18434 Brazil.111/97c 1
Philippines. 12123/84b 1984 U18435 Brazil.233/97c 1
Puerto Rico.1650/86b 1986 U18436 Brazil.409/97c 1
Puerto Rico.28/92b 1992 AY152196 Brazil.MR/01c 2
Puerto Rico.M5/82b 1982 AY152336 Cambodiac N
Puerto Rico.M32/85b 1985 AY152856 China.04/85c 1
Puerto Rico.M33/85b 1985 AY152857 China.80-2c N
Puerto Rico.69/87b 1987 AY152252 China.43/87c 1
a Year of sampling.
b E gene sequence.
c Complete coding region sequence.
d Year of sampling not available.
e Geographical origin not available.Phylogenetic analysis
A total of 53 DENV-4 E gene sequences from DF and
DHF patients in Thailand were obtained. These sequences
were combined with 56 DENV-4 E gene sequences taken
from GenBank representing a wide range in geographiceara Accession Country of origin Yeara Accession
990 AY152855 China.44/89c 1989 AF204177
994 AY152084 China.FJ11/99c 1999 AF359579
998 AY152056 China.Guangzhou/80c 1980 AF350498
978 U18437 Cote D’Ivoire.Abidjan/98c 1998 AF298807
982 AY152386 Djibouti/98c 1998 AF298808
994 AY152372 Dominica/81c 1981 AF326573
994 AY152373 French Guiana/89c 1989 AF226687
994 AY152374 Philippines.H87/57c 1957d M93130
979 U18438 Jamaica.N1409/83c 1983 M20558
985 U18439 Martinique/98c 1998 AF208496
963 U18440 Martinique/99c 1999 AY099337
978 U18441 Japan.Mochizuki/43c 1943 AB074760
984 U18422 Nauru Island.A5AZ5c NAd U88536
994 AF231726 Nauru Island.WestPacc NAd U88535
999 AB111087 New Guinea.C/44c 1944 AF038403
982 AY152382 Paraguay.259/00c 2000 AF514883
982 AY152383 Paraguay.280/00c 2000 AF514878
984 AY152380 Peru.IQT2913/96c 1996 AF100468
984 AY152381 Peru.IQT1797/95c 1995 AF100467
994 AY152377 BR64022c,e NAd AF489932
Ad AF180818 Singapore.S275/90c 1990 M87512
988 AB074761 Sri Lanka/00c 2000 AY099336
000 AY206457 Thailand.NH-36/93c 1993 AF169679
000 AF514885 Thailand.NH-55/93c 1993 AF169681
000 AF514889 Thailand.NH-73/93c 1993 AF169686
000 AF514876 Thailand.NH-76/93c 1993 AF169687
993 AY037116 Thailand.NH-81/93c 1993 AF169688
990 AF226685 Thailand.NH-p14/93c 1993 AF022439
997 AF311956 Thailand.K0008/94c 1994 AF100459
997 AF311958 Thailand.K0010/94c 1994 AF100460
997 AF311957 Thailand.C0167/96c 1996 AF100464
001 AF513110 Thailand.16681/64c 1964 U87411
Ad AF309641 Venezuela.131/92c 1992 AF100469
985 AF119661 Venezuela.2/87c 1987 AF100465
A AF317645 Venezuela.Mara4/90c 1990 AF100466
987 AF204178
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and two sylvatic strains isolated from monkeys in Malaysia.
This produced a total data set of 109 E gene sequences,
1485-bp long, on which phylogenetic analysis could be
conducted. Known recombinant sequences were excluded
from the analysis. For six isolates of DENV-4 from
Thailand, the complete coding region of the viral genome
was also available for analysis. These sequences were
combined with 52 complete coding region sequences taken
from GenBank representing all four serotypes of dengue
virus, including two other DENV-4 isolates. This produced
a total data set of 58 complete coding region sequences,
10185-bp long. Both sequence alignments are available
from the others by request.
For both the E gene and complete coding region
sequences, maximum likelihood (ML) phylogenetic trees
were estimated using the GTR + G + I model of nucleotide
substitution, with the GTR substitution matrix, the base
composition, the gamma distribution of among-site rate
variation (G) and the proportion of invariant sites (I) all
estimated from the data. All parameter values are available
from the authors on request. To assess the robustness of
particular phylogenetic groupings, a bootstrap resampling
analysis was performed using 1000 replicate neighbor-
joining (NJ) trees under the ML substitution model
described above. All phylogenetic analyses were performed
using the PAUP* package (Swofford, 2002).
Selection pressures
To determine the nature of the selection pressures acting
on DENV-4, and particularly the incidence of positive
selection, an analysis was made of the ratio of non-
synonymous (dN) to synonymous (dS) nucleotide changes
per site, with dN N dS indicative of positive selection. This
analysis was conducted on (i) a sample of 60 E gene
sequences representing the full global diversity of DENV-4,
and (ii) the eight DENV-4 viruses for which sequences of
the complete coding region were available so that selection
pressures could be assessed on a gene-by-gene basis. Two
approaches were used to measure dN and dS. First, the mean
dN/dS ratio for each DENV-4 gene was measured using the
pairwise method of Nei and Gojobori (1986) as imple-
mented in the MEGA2 sequence analysis package (Kumar
et al., 2001). Second, to obtain a codon-specific measure of
selection pressures acting on the 60 E gene sequences
(including a test for positive selection), the maximum
likelihood method in the PAML sequence analysis package
(program CODEML) was employed (Yang, 1997; Yang et
al., 2000). This involved the statistical comparison of four
models of codon evolution that differ in how dN and dS vary
among codons or lineages. To analyze selection pressures at
specific codons, we compared the M7 and M8 models; the
former specifies that individual codons can take 1 of 10
categories of dN/dS, all estimated from the data but where no
category has dN/dS N 1.0 so that the model only allowsneutral evolution, while M8 also allows positive selection
by adding an 11th category of codons at which dN/dS can
exceed 1.0. Significant evidence for positive selection is
obtained if M8 significantly rejects M7 under a likelihood
ratio test and at least one category of codons in M8 has a dN/
dS ratio N 1. To analyze selection pressures along each
lineage of the DENV-4 phylogeny, we compared (again
using a likelihood ratio test) model M0, in which each
lineage has the same dN/dS ratio, with FR (the bfree ratioQ
model) in which lineages are allowed to take on individual
values of dN/dS.
Rates of molecular evolution
To estimate the overall rate of nucleotide substitution of
DENV-4 in Thailand, we compared the differences in
branch lengths according to sampling time for 47 of the
Thai viruses sampled here, which fell into genotype I of
the virus. This analysis was undertaken using the Bayesian
Markov Chain Monte Carlo (MCMC) method available in
the BEAST package (http://www.evolve.zoo.ox.ac.uk/
beast/) using a burn-in of 300000 and a final chain length
of 3 million, giving an effective sample size of 709098.
As with the maximum likelihood trees estimated above,
the GTR + G + I model of nucleotide substitution was
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